Target cells | Biological actions of HMGB1 |
---|---|
Dendritic cells | Maturation and capacity to home to lymph nodes. |
Monocytes/macrophages | Potential proinflammatory cytokine production in collaboration with PAMP or DAMP molecules. |
 | Induction of MMPs. |
 | Promotes migration of monocytes. |
Neutrophils | Enhances chemotaxis. |
 | Prevents apoptosis. |
T lymphocytes | Proliferation and polarization toward TH1. |
B lymphocytes | Potentiates activation by DNA-IgG complexes. |
Epithelial cells | Increased enterocyte permeability causing barrier dysfunction. |
 | Bactericidal effects. |
Platelets | Expressed on cell surface by activated platelets. |
Osteoclasts | Enhances osteoclast formation and TNF release by direct binding to the TNF promoter. |
Endothelial cells | Proangiogenic. |
 | Upregulation of adhesion molecules. |
Smooth muscle cells | Causes migration and proliferation. |
Neurons | Induces neurite outgrowth. |
Astrocytes | Proinflammatory activity, including chemotactic signals and MMP formation. |
 | Induces glutamate release. |
Cardiac myocytes | Negative inotropic effects. |
 | Involved in repair. |
Stem cells | Chemotaxis. |
 | Promotes differentiation. |
Tumor cells | Enhances invasiveness. |
 | MMP formation. |
 | Strong HMGB1 overexpression. |